Matthias Preusser

Matthias Preusser

Medizinische Universität Wien

H-index: 88

Europe-Austria

About Matthias Preusser

Matthias Preusser, With an exceptional h-index of 88 and a recent h-index of 68 (since 2020), a distinguished researcher at Medizinische Universität Wien, specializes in the field of Medical Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Theranostics in Neurooncology: Heading Toward New Horizons

A comparison of 7 Tesla MR spectroscopic imaging and 3 Tesla MR fingerprinting for tumor localization in glioma patients

The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review

The outcomes measured and reported in intracranial meningioma clinical trials: a systematic review

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative

DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma

Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial

Matthias Preusser Information

University

Medizinische Universität Wien

Position

___

Citations(all)

33335

Citations(since 2020)

23499

Cited By

17519

hIndex(all)

88

hIndex(since 2020)

68

i10Index(all)

344

i10Index(since 2020)

279

Email

University Profile Page

Medizinische Universität Wien

Matthias Preusser Skills & Research Interests

Medical Oncology

Top articles of Matthias Preusser

Title

Journal

Author(s)

Publication Date

Theranostics in Neurooncology: Heading Toward New Horizons

Journal of Nuclear Medicine

Nelleke Tolboom

Antoine Verger

Nathalie L Albert

Francesco Fraioli

Eric Guedj

...

2024/2/1

A comparison of 7 Tesla MR spectroscopic imaging and 3 Tesla MR fingerprinting for tumor localization in glioma patients

Cancers

Philipp Lazen

Pedro Lima Cardoso

Sukrit Sharma

Cornelius Cadrien

Thomas Roetzer-Pejrimovsky

...

2024/2/26

The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review

Christopher P Millward

Abdurrahman I Islim

Terri S Armstrong

Heather Barrington

Sabrina Bell

...

2024/3/19

The outcomes measured and reported in intracranial meningioma clinical trials: a systematic review

Christopher P Millward

Sumirat M Keshwara

Terri S Armstrong

Heather Barrington

Sabrina Bell

...

2024/3/2

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

Nathalie L Albert

Norbert Galldiks

Benjamin M Ellingson

Martin J van den Bent

Susan M Chang

...

2024/1/1

Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative

Neuro-oncology practice

Emilie Le Rhun

Florien Boele

Giuseppe Minniti

Norbert Galldiks

Martin Taphoorn

...

2024/2/1

DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma

Targeted Oncology

Julia Maria Ressler

Erwin Tomasich

Teresa Hatziioannou

Helmut Ringl

Gerwin Heller

...

2024/2/24

Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial

Neuro-oncology

Patrick Roth

Thierry Gorlia

Jaap C Reijneveld

Filip de Vos

Ahmed Idbaih

...

2024/3/19

Alternating chemotherapy with VDC-IE as effective first-line treatment in a patient with SMARCA4-deficient undifferentiated tumor

memo-Magazine of European Medical Oncology

Petar Popov

Oskar Steinbrecher

Anke Scharrer

Markus Raderer

Thomas Brodowicz

...

2024/4/22

Celebrating the 30th Anniversary of the European Association of Neuro-Oncology (EANO)

Neuro-oncology

Matthias Preusser

Michael Platten

Susan C Short

2024/3/2

Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial

European Journal of Cancer

Emilie Le Rhun

Thierry Gorlia

Jörg Felsberg

Joost Jongen

Claude-Alain Maurage

...

2024/2/1

Inequalities in access to neuro-oncology supportive care and rehabilitation: a survey of healthcare professionals’ perspectives

Neuro-Oncology Practice

Florien Boele

Lena Rosenlund

Sara Nordentoft

Sara Melhuish

Emma Nicklin

...

2024/3/15

Thrombosis rates in patients with cancer receiving immune checkpoint inhibitors: results from a prospective cohort study

Hämostaseologie

C Englisch

F Moik

D Steiner

A Starzer

A Berghoff

...

2024/2

Improving long-term outcomes in pediatric low-grade glioma

Nature Cancer

Johannes Gojo

Matthias Preusser

2024/3/1

Locoregional delivery of CAR-T cells–breaking the spell in glioblastoma?

Marjolein Geurts

Matthias Preusser

2024/4/9

Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer

memo-Magazine of European Medical Oncology

Julia M Berger

Pia Gattinger

Maximilian J Mair

Anna S Berghoff

Rudolf Valenta

...

2024/2

Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells

International Journal of Oncology

Thomas W Grunt

Renate Wagner

Alexander Ries

Anna S Berghoff

Matthias Preusser

...

2024/3/1

The more the merrier? Evidence and efficacy of immune checkpoint-and tyrosine kinase inhibitor combinations in advanced solid cancers

Angelika M Starzer

Ladislaia Wolff

Petar Popov

Barbara Kiesewetter

Matthias Preusser

...

2024/3/15

Incidence and outcomes of bleeding events in patients with cancer: results from a prospective cohort study

Hämostaseologie

C Englisch

F Moik

D Steiner

A Berghoff

M Preusser

...

2024/2

The plasma miRNome and venous thromboembolism in high‐grade glioma: miRNA Sequencing of a nested case–control cohort

Journal of Cellular and Molecular Medicine

Friedrich Erhart

Georg Widhalm

Barbara Kiesel

Matthias Hackl

Andreas Diendorfer

...

2024/4

See List of Professors in Matthias Preusser University(Medizinische Universität Wien)

Matthias Preusser FAQs

What is Matthias Preusser's h-index at Medizinische Universität Wien?

The h-index of Matthias Preusser has been 68 since 2020 and 88 in total.

What are Matthias Preusser's top articles?

The articles with the titles of

Theranostics in Neurooncology: Heading Toward New Horizons

A comparison of 7 Tesla MR spectroscopic imaging and 3 Tesla MR fingerprinting for tumor localization in glioma patients

The outcomes measured and reported in observational studies of incidental and untreated intracranial meningioma: A systematic review

The outcomes measured and reported in intracranial meningioma clinical trials: a systematic review

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group

Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative

DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma

Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial

...

are the top articles of Matthias Preusser at Medizinische Universität Wien.

What are Matthias Preusser's research interests?

The research interests of Matthias Preusser are: Medical Oncology

What is Matthias Preusser's total number of citations?

Matthias Preusser has 33,335 citations in total.

What are the co-authors of Matthias Preusser?

The co-authors of Matthias Preusser are Wolfgang Wick, Herbert Budka, Pabinger Ingrid or Pabinger-Faching Ingrid, Monika Hegi, Olivier Chinot.

Co-Authors

H-index: 141
Wolfgang Wick

Wolfgang Wick

Heidelberg University

H-index: 103
Herbert Budka

Herbert Budka

Medizinische Universität Wien

H-index: 96
Pabinger Ingrid or Pabinger-Faching Ingrid

Pabinger Ingrid or Pabinger-Faching Ingrid

Medizinische Universität Wien

H-index: 83
Monika Hegi

Monika Hegi

Université de Lausanne

H-index: 74
Olivier Chinot

Olivier Chinot

Aix-Marseille Université

academic-engine